PACS Group (PACS) and Its Rivals Head-To-Head Comparison

PACS Group (NYSE:PACS) is one of 93 public companies in the “Medical Services” industry, but how does it weigh in compared to its rivals? We will compare PACS Group to similar companies based on the strength of its dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Earnings and Valuation

This table compares PACS Group and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
PACS Group	$3.11 billion	$112.87 million	40.94
PACS Group Competitors	$13.14 billion	$239.88 million	35.02

PACS Group’s rivals have higher revenue and earnings than PACS Group. PACS Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

58.1% of shares of all “Medical Services” companies are held by institutional investors. 13.2% of shares of all “Medical Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares PACS Group and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PACS Group	N/A	N/A	N/A
PACS Group Competitors	-785.87%	-50.16%	-11.77%

Analyst Recommendations

This is a summary of recent recommendations and price targets for PACS Group and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	1	1	3	0	2.40
PACS Group Competitors	590	2431	5032	179	2.58

PACS Group presently has a consensus target price of $26.25, indicating a potential upside of 106.86%. As a group, “Medical Services” companies have a potential upside of 350.45%. Given PACS Group’s rivals stronger consensus rating and higher probable upside, analysts clearly believe PACS Group has less favorable growth aspects than its rivals.

Risk & Volatility

PACS Group has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500. Comparatively, PACS Group’s rivals have a beta of 1.49, indicating that their average share price is 49% more volatile than the S&P 500.

Summary

PACS Group rivals beat PACS Group on 9 of the 13 factors compared.

About PACS Group

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.